- Home
- LXEO vs PIM Comparison
LXEO vs PIM Comparison
Compare LXEO & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- PIM
- Stock Information
- Founded
- LXEO 2017
- PIM 1988
- Country
- LXEO United States
- PIM United States
- Employees
- LXEO N/A
- PIM N/A
- Industry
- LXEO
- PIM Finance Companies
- Sector
- LXEO
- PIM Finance
- Exchange
- LXEO Nasdaq
- PIM Nasdaq
- Market Cap
- LXEO 140.6M
- PIM 159.3M
- IPO Year
- LXEO 2023
- PIM N/A
- Fundamental
- Price
- LXEO $4.10
- PIM $3.31
- Analyst Decision
- LXEO Strong Buy
- PIM
- Analyst Count
- LXEO 5
- PIM 0
- Target Price
- LXEO $22.80
- PIM N/A
- AVG Volume (30 Days)
- LXEO 919.4K
- PIM 57.5K
- Earning Date
- LXEO 03-24-2025
- PIM 01-01-0001
- Dividend Yield
- LXEO N/A
- PIM 8.28%
- EPS Growth
- LXEO N/A
- PIM N/A
- EPS
- LXEO N/A
- PIM 0.05
- Revenue
- LXEO N/A
- PIM N/A
- Revenue This Year
- LXEO N/A
- PIM N/A
- Revenue Next Year
- LXEO N/A
- PIM N/A
- P/E Ratio
- LXEO N/A
- PIM $63.80
- Revenue Growth
- LXEO N/A
- PIM N/A
- 52 Week Low
- LXEO $2.32
- PIM $2.90
- 52 Week High
- LXEO $19.50
- PIM $3.28
- Technical
- Relative Strength Index (RSI)
- LXEO 57.61
- PIM 53.21
- Support Level
- LXEO $3.75
- PIM $3.27
- Resistance Level
- LXEO $4.59
- PIM $3.33
- Average True Range (ATR)
- LXEO 0.48
- PIM 0.04
- MACD
- LXEO 0.24
- PIM 0.00
- Stochastic Oscillator
- LXEO 76.89
- PIM 62.50
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.
About PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.